By Market Intelligence Team

OPEN MINDS, The Behavioral Health & Social Service Industry Analyst Industry Feature Despite regulations aimed at ensuring access to all medically necessary drugs, patients enrolled in Medicare Part D plans are finding utilization management (UM) restrictions are limiting their access to several types of generic and name-brand medications. All Medicare Part D plan providers cover substantially all mental health drugs. However, many plans have either failed to provide coverage or have instituted UM techniques that restrict consumer access to antidepressant and antipsychotic medications. This is bad news for the nearly . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options
OPEN MINDS, The Behavioral Health & Social Service Industry Analyst Industry Feature Despite regulations aimed at ensuring access to all medically necessary drugs, patients enrolled in Medicare Part D plans are finding utilization management (UM) restrictions are limiting their access to several types of generic and name-brand medications. All Medicare Part D plan providers cover substantially all mental health drugs. However, many plans have either failed to provide coverage or have instituted UM techniques that restrict consumer access to antidepressant and antipsychotic medications. This is bad news for the nearly . . .
Restricted Content

You must be a member to view this resource.

Log in | Sign up or learn more about membership options

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!